| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $216.8M | +19.5% | +113.4% |
| R&D Expense | $21.6M | -13.7% | -21.8% |
| SG&A Expense | $52.0M | -19.3% | +27.2% |
| Operating Income | $32.6M | +281.5% | +153.7% |
| Interest Expense | $13.5M | -29.7% | -2.1% |
| Pre-tax Income | $24.3M | +133.9% | +135.9% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $753.2M | +4.8% | — |
| Short-term Investments | $2.3M | +1.0% | — |
| Accounts Receivable | $26.7M | -47.5% | — |
| Current Assets | $854.2M | +2.5% | — |
| Total Assets | $984.6M | +3.1% | — |
| Current Liabilities | $86.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $38.4M | — | — |
| Capital Expenditures | $11.2M | — | — |
| Investing Cash Flow | -$11.2M | — | — |
| Financing Cash Flow | $661.6M | — | — |
| Free Cash Flow | $27.2M | — | — |
| — |
| — |
| Net Income | $24.3M | +133.9% | +135.9% |
| EPS (Basic) | $0.09 | +101.1% | +103.5% |
| EPS (Diluted) | $0.08 | +101.0% | +103.1% |
| -4.6% |
| — |
| Long-term Debt | $375.9M | +0.7% | — |
| Total Liabilities | $506.2M | +0.8% | — |
| Stockholders' Equity | $478.4M | +5.6% | +119.6% |